-+ 0.00%
-+ 0.00%
-+ 0.00%

Clearmind Medicine releases update on intranasal MEAI formulation retention study

PUBT·07/16/2026 13:30:16
Listen to the news
Clearmind Medicine releases update on intranasal MEAI formulation retention study
  • Clearmind Medicine reported positive ex vivo mucoadhesion results for an intranasal MEAI formulation, showing higher nasal tissue retention than a standard solution.
  • Data support its intranasal program for Alcohol Use Disorder, aiming to extend nasal residence time to improve absorption and dosing consistency.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160930PRIMZONEFULLFEED9763410) on July 16, 2026, and is solely responsible for the information contained therein.